For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jan 21, 2025  1 month, 9 hours, 11 minutes ago

COVID-19 and POLG-Related Mitochondrial Disease

2017 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 and POLG-Related Mitochondrial Disease
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jan 21, 2025  1 month, 9 hours, 11 minutes ago
Medical News: Introduction to Mitochondrial Diseases and Viral Triggers
In a recent case study, a six-year-old girl presented with severe health complications following a COVID-19 infection, revealing a genetic predisposition to a rare mitochondrial disorder known as Alpers-Huttenlocher syndrome (AHS). This case offers insights into how viral infections, especially COVID-19, can act as triggers for underlying genetic conditions, intensifying their progression.


COVID-19 and POLG-Related Mitochondrial Disease

The study was conducted by researchers from the Department of Pediatrics and the Clinic of Genetic Medicine at Jessenius Faculty of Medicine and University Hospital in Martin, Slovakia. Their findings emphasize the importance of early genetic evaluations in children presenting with unexplained seizures, especially in the context of mitochondrial dysfunction.
 
Understanding POLG Mutations and Mitochondrial Dysfunction
Mitochondria, often referred to as the powerhouses of cells, generate energy through a complex process called oxidative phosphorylation. This energy is vital for numerous cellular functions, and disruptions can lead to mitochondrial diseases. The POLG gene, located on chromosome 15, is critical for mitochondrial DNA replication and repair. Mutations in POLG - like the c.1399G>A; p.Ala467Thr variant identified in this case - are among the leading causes of inherited mitochondrial disorders.
 
POLG-related diseases exhibit a wide range of symptoms, including seizures, cognitive decline, and organ dysfunction. This Medical News report highlights that viral infections, such as SARS-CoV-2, can worsen mitochondrial function by increasing oxidative stress and disrupting cellular energy production. These factors can precipitate severe outcomes in individuals with underlying vulnerabilities.
 
The Case Presentation: A Devastating Course
The patient, a previously healthy child, began experiencing acute seizures accompanied by fever, nausea, and lethargy. Despite aggressive treatment with anti-seizure medications and other supportive measures, her condition rapidly progressed to super-refractory status epilepticus. A detailed genetic analysis ultimately revealed the homozygous POLG mutation associated with AHS.

Earlier in life, the child had episodic symptoms, including ataxia and vomiting, which were misdiagnosed as migraines. This underscores the difficulty in identifying mitochondrial diseases in asymptomatic or mildly symptomatic individuals until a significant trigger, such as a viral infection, accelerates the disease process. COVID-19 was likely the critical factor that exacerbated her condition.
 
SARS-CoV-2’s Role in Mitochondrial Dysfunction
COVID-19’s impact on mitochondrial health is an area of growing research. The virus is known to disrupt mitochondrial processes, including energy production, antiviral signaling, and immune response regulation. In the presented case, SARS-CoV-2 likely intensified mitochondrial dysfunction, leading to rapid clinical decline.
/> Studies suggest that viruses can impair mitochondrial function by hijacking cellular energy for viral replication and increasing oxidative stress. This process can reduce the production of ATP - the energy currency of cells - and exacerbate existing mitochondrial dysfunction. For individuals with POLG mutations, such disruptions can lead to catastrophic outcomes, as seen in this child.
 
Key Findings from the Study
-Genetic Analysis: The homozygous c.1399G>A (p.Ala467Thr) mutation in POLG was identified, confirming the diagnosis of AHS. This mutation is among the most common pathogenic POLG variants in the Caucasian population.
 
-Neurological Deterioration: The child’s condition included refractory seizures, developmental regression, and ultimately, multiorgan failure.
 
-Role of COVID-19: Serological tests indicated a recent SARS-CoV-2 infection, which likely acted as a trigger for the progression of AHS. The virus’s ability to impair mitochondrial function and disrupt immune responses was central to the disease’s rapid progression.
 
-Therapeutic Challenges: Despite intensive treatment, including anti-seizure medications, immunotherapies, and supportive care, the child’s condition deteriorated. The role of valproic acid, an anti-seizure drug, in potentially exacerbating liver dysfunction was also noted.
 
Broader Implications of the Findings
This case underscores the need for heightened awareness of mitochondrial diseases and their interactions with environmental triggers. Early genetic testing can guide clinicians in identifying at-risk individuals and tailoring treatments to avoid medications or interventions that could exacerbate mitochondrial dysfunction.
 
Conclusion
The tragic outcome of this case highlights the profound impact of viral infections, such as COVID-19, on individuals with underlying genetic vulnerabilities. For this patient, the combination of a homozygous POLG mutation and a SARS-CoV-2 infection led to an irreversible decline, illustrating the critical interplay between genetic predisposition and environmental factors. Recognizing and addressing these interactions is essential for improving diagnostic and therapeutic approaches.
 
For healthcare professionals, this case serves as a reminder of the importance of early genetic evaluations, especially in pediatric patients presenting with unexplained refractory seizures. By identifying genetic vulnerabilities early, clinicians can potentially mitigate rapid disease progression and improve outcomes.
 
The study findings were published in the peer-reviewed journal: Cureus.
https://www.cureus.com/articles/280725-covid-19-infection-as-a-possible-trigger-for-polg-related-mitochondrial-disease-a-case-report#!/
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
 
https://www.thailandmedical.news/news/mitochondrial-flux-and-its-disruption-in-viral-infections-such-as-covid-19
 
https://www.thailandmedical.news/news/covid-19-causes-skeletal-muscle-and-mitochondrial-damage-that-contributes-to-myalgic-encephalomyelitis-chronic-fatigue-syndrome
 
https://www.thailandmedical.news/news/covid-19-causes-disruptions-in-blood-brain-barrier-via-mitochondria-impairment-and-endothelial-dysfunction
 
https://www.thailandmedical.news/articles/coronavirus

MOST READ

Dec 11, 2024  2 months ago
Nikhil Prasad
Nov 26, 2024  3 months ago
Nikhil Prasad
Nov 19, 2024  3 months ago
Nikhil Prasad
Nov 12, 2024  3 months ago
Nikhil Prasad
Nov 05, 2024  4 months ago
Nikhil Prasad
Nov 05, 2024  4 months ago
Nikhil Prasad
Jul 25, 2024  7 months ago
Nikhil Prasad
Jul 24, 2024  7 months ago
Nikhil Prasad